From Financialisation to Innovation in UK Big Pharma: AstraZeneca and GlaxoSmithKline

From Financialisation to Innovation in UK Big Pharma: AstraZeneca and GlaxoSmithKline

Cambridge University Press
SKU:
9781009278164
|
UPC:
9781009278164
£17.78
(No reviews yet)
Condition:
New
Current Stock:
Adding to cart… The item has been added
Description
This Element analyses the tension between innovation and financialisation in the UK pharmaceutical industry, focusing on AstraZeneca and GlaxoSmithKline. This title is also available as Open Access on Cambridge Core.


  • | By (Author): OEner Tulum (The Academic-Industry Research Network), Antonio Andreoni (School of Oriental and African Studies, University of London), William Lazonick (The Academic-Industry Research Network) (Author)
  • | Publisher: Cambridge University Press
  • | Publication Date: Dec 22, 2022
  • | Country of Publication: United Kingdom
  • | Number of Pages: 75 pages
  • | Language: NULL
  • | Binding: Paperback / softback
  • | ISBN-10: 1009278169
  • | ISBN-13: 9781009278164
Additional Information
By (Author):
OEner Tulum (The Academic-Industry Research Network), Antonio Andreoni (School of Oriental and African Studies, University of London), William Lazonick (The Academic-Industry Research Network) (Author)
Publisher:
Cambridge University Press
Publication Date:
Dec 22, 2022
Country of Publication:
United Kingdom
Language:
NULL
Number of pages:
75 pages
Binding:
Paperback / softback
ISBN-10:
1009278169
ISBN-13:
9781009278164
Related Products